Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by topic
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by topic
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 8, Issue 1
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Basic tumor immunology
Original research
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Online download statistics by month:
Online download statistics by month: April 2020 to August 2020
Abstract
Full
Pdf
Apr 2020
263
263
201
May 2020
218
218
78
Jun 2020
108
108
39
Jul 2020
76
76
27
Aug 2020
56
57
24
Total
721
722
369
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF